AI Biomedical Inc.

News

Stay up to date with the latest from AI Biomedical Inc.

2026.05.21 Upcoming Event

Speaking at 8th Regenerative Medicine EXPO Tokyo

CEO Sakurada will present "The Future of Next-Generation Medical Manufacturing Pioneered by Regenerative Medicine x AI" at Session RM-S4 during INTERPHEX Week Tokyo 2026. Makuhari Messe, May 21 (Thu) 16:00-17:00.

2026.05.04 Media

Featured on TV Tokyo "TOKYO Hot Info"

AI BIOMEDICAL was featured as a company utilizing Tokyo Innovation Base, as part of SusHi Tech Tokyo 2026 initiatives.

2026.04.09 Speaking

Chuo University Alumni Entrepreneur Lecture

CEO Sakurada and Chairman Semmoto spoke on "AI Regenerative Medicine Revolution by AI BIOMEDICAL — A Challenge from Chuo University Science & Engineering" at Korakuen Campus.

2026.03.04 Speaking

10th Cell Manufacturing Kotozukuri Symposium

Presented at the symposium on regulatory systems for cell manufacturing held at Osaka University, Toyonaka Campus. Approximately 95 participants attended.

2026.01.14 Press Release

AI Biomedical Selected for METI's "Japan Innovation Campus" in Silicon Valley

Selected as a 4th cohort coworking member of the Ministry of Economy, Trade and Industry's Silicon Valley hub "Japan Innovation Campus." Full-scale U.S. business operations to begin in 2026.

2025.11.07 Announcement

AIBM Quantum Dream Studio Tokyo Opens at Kotsu Kaikan

A new R&D hub opened at 6F Tokyo Kotsu Kaikan, 2-10-1 Yurakucho, Chiyoda-ku, Tokyo, promoting R&D using quantum AI and advanced Physical AI technology.

2025.11.05 Press Release

Toward the World's First "Physical AI" Medical Platform — Project Hawaii Launches

AIBM, Edison AI, and BeMap launch a 3-year plan to synchronize the real and virtual worlds through digital twin, bio-3D printer, and communication technologies.

2025.10.15 Press Release

AI Biomedical's "AI Regenerative Medicine Revolution" Launches in Full

New management structure announced. World-first QUANTUM method (AI × 5-axis 3D bioprinting × digital twin) aims to develop pediatric regenerative artificial hearts.

2023.12.08 Announcement

Artissue Inc., a Regenerative Medicine Design Company, Founded

Artissue Inc., predecessor of AI Biomedical Inc., founded in Chiyoda-ku, Tokyo, with a mission to "create happiness for the next generation through regenerative organ revolution."